نتایج جستجو برای: neoadjuvant

تعداد نتایج: 15052  

2016
Carolin Nestle-Krämling Edwin Bölke Wilfried Budach Christoph Andree

Neoadjuvant radio chemotherapy and immediate reconstruction for breast cancer are still under debate. But there are recent abstracts and articles which show that neoadjuvant radio chemotherapy is feasible and could improve the clinical outcome of breast cancer patients. The aim of this review is to present the authors' techniques and approaches with regard to neoadjuvant radiation of breast can...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2007
M Kaufmann G von Minckwitz H D Bear A Buzdar P McGale H Bonnefoi M Colleoni C Denkert W Eiermann R Jackesz A Makris W Miller J-Y Pierga V Semiglazov A Schneeweiss R Souchon V Stearns M Untch S Loibl

Neoadjuvant (primary systemic) treatment has become a standard option for primary operable disease for patients who are candidates for adjuvant systemic chemotherapy, irrespective of the size of the tumor. Because of new treatments and new understandings of breast cancer, however, recommendations published in 2006 regarding neoadjuvant treatment for operable disease required updating. Therefore...

2014
Michaela Aichler Martin Motschmann Uta Jütting Birgit Luber Karen Becker Katja Ott Florian Lordick Rupert Langer Marcus Feith Jörg Rüdiger Siewert Axel Walch

Neoadjuvant platin-based therapy is accepted as a standard therapy for advanced esophageal adenocarcinoma (EAC). Patients who respond have a better survival prognosis, but still a significant number of responder patients die from tumor recurrence. Molecular markers for prognosis in neoadjuvantly treated EAC patients have not been identified yet. We investigated the epidermal growth factor recep...

2015
Wenzhao Zhong Xuening Yang Honghong Yan Xuchao Zhang Jian Su Zhihong Chen Riqiang Liao Qiang Nie Song Dong Qing Zhou Jinji Yang Haiyan Tu Yi-Long Wu

BACKGROUND Neoadjuvant erlotinib and customized adjuvant therapy are appealing but controversial. The purpose of this study was to evaluate the role of biomarker-guided neoadjuvant treatment strategy in patients with IIIA-N2 non-small cell lung cancer (NSCLC) stratified by epidermal growth factor receptor (EGFR) mutation status. FINDINGS Patients with resectable histologically documented stag...

Journal: :Rhode Island medical journal 2014
WILLIAM M. SIKOV

gery, cancer had been eliminated from the breast in 42 percent of these patients and from both the breast and lymph nodes in 39 percent. These proportions increased to 50 percent and 43 percent, respectively, for the 110 patients who were randomly assigned to standard neoadjuvant chemotherapy plus bevacizumab; 53 percent and 49 percent, respectively, for the 113 patients who were randomly assig...

2011
Shaji Thomas Apurva Prakash Vinay Goyal Manju Bala Popli Shilpi Agarwal Monisha Choudhury

Introduction. Controversy continues over the appropriate timing of sentinel lymph node (SLN) biopsy in locally advanced breast cancer (LABC) patients receiving neoadjuvant chemotherapy. We evaluated the feasibility and accuracy of SLN biopsy in LABC patients with cytology-proven axillary nodal metastasis who become clinically node-negative after neoadjuvant chemotherapy. Materials. 30 consecuti...

2013
Xuemei Ji Conghua Xie Desheng Hu Xia Fan Yajuan Zhou Yingjie Zheng

BACKGROUND To evaluate the contribution of chemotherapy for patients with locoregionally advanced nasopharyngeal carcinoma (NPC) treated by intensity modulated radiotherapy (IMRT) and to identify the optimal combination treatment strategy. PATIENTS AND METHODS Between 2006 and 2010, 276 patients with stage II-IVb NPC were treated by IMRT alone or IMRT plus chemotherapy. Cisplatin-based chemot...

Journal: :Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 2010
Kenji Shiraishi Hiroaki Nomori Yasuomi Ohba Masahiro Kaji Takeshi Mori Hidekatsu Shibata Natsuo Oya Jiichiro Sasaki

BACKGROUND The efficacy of fluorodeoxyglucose-positron emission tomography (FDG-PET) for predicting pathological tumor response and prognosis after neoadjuvant chemoradiotherapy followed by surgery in locally advanced nonsmall cell lung cancer (NSCLC) was compared to the predictive value of tumor size as determined by computed tomography (CT). METHODS Thirty-seven consecutive NSCLC patients w...

2015
Guo-Yi Zhang Yue-Jian Wang Jian-Ping Liu Xin-Han Zhou Zhi-Feng Xu Xiang-Ping Chen Tao Xu Wei-Hong Wei Yang Zhang Ying Huang

PURPOSE To explore the potential of diffusion-weighted (DW) magnetic resonance imaging (MRI) using apparent diffusion coefficient (ADC) for predicting the response to neoadjuvant chemotherapy in nasopharyngeal carcinoma (NPC). METHODS AND MATERIALS Ninety-two consecutive patients with NPC who underwent three cycles of neoadjuvant chemotherapy were retrospectively analyzed. DW and anatomical M...

Journal: :The Annals of thoracic surgery 2014
Sarah Bekkar Caroline Gronnier Mathieu Messager William B Robb Guillaume Piessen Christophe Mariette

BACKGROUND Signet ring cell (SRC) tumors have a worse prognosis when compared with non-SRC tumors, and neoadjuvant chemotherapy has been suggested to be an ineffective treatment strategy. Preoperative radiochemotherapy, of already proven efficacy for esophagogastric junction adenocarcinomas (EGJA), could be an alternative neoadjuvant strategy for SRC EGJA. The aim of this retrospective study wa...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید